DE60009146D1 - Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten - Google Patents

Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten

Info

Publication number
DE60009146D1
DE60009146D1 DE60009146T DE60009146T DE60009146D1 DE 60009146 D1 DE60009146 D1 DE 60009146D1 DE 60009146 T DE60009146 T DE 60009146T DE 60009146 T DE60009146 T DE 60009146T DE 60009146 D1 DE60009146 D1 DE 60009146D1
Authority
DE
Germany
Prior art keywords
viral infections
contain
pharmaceutical preparations
dna viral
loop diuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009146T
Other languages
English (en)
Other versions
DE60009146T2 (de
Inventor
Edward Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930811.6A external-priority patent/GB9930811D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023198A external-priority patent/GB0023198D0/en
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Application granted granted Critical
Publication of DE60009146D1 publication Critical patent/DE60009146D1/de
Publication of DE60009146T2 publication Critical patent/DE60009146T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60009146T 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten Expired - Lifetime DE60009146T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9930811.6A GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB9930811 1999-12-30
GB0000683 2000-01-12
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023198 2000-09-21
GB0023198A GB0023198D0 (en) 1999-12-30 2000-09-21 Treatment of DNA viral infections
PCT/GB2000/004793 WO2001049242A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Publications (2)

Publication Number Publication Date
DE60009146D1 true DE60009146D1 (de) 2004-04-22
DE60009146T2 DE60009146T2 (de) 2005-02-17

Family

ID=27255465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009146T Expired - Lifetime DE60009146T2 (de) 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten

Country Status (17)

Country Link
US (1) US6894030B2 (de)
EP (1) EP1242119B1 (de)
JP (1) JP2003519163A (de)
KR (1) KR100843790B1 (de)
CN (1) CN1414863A (de)
AT (1) ATE261737T1 (de)
AU (1) AU777339B2 (de)
BR (1) BR0016831A (de)
CA (1) CA2395016C (de)
DE (1) DE60009146T2 (de)
DK (1) DK1242119T3 (de)
ES (1) ES2218254T3 (de)
IL (1) IL150286A0 (de)
MX (1) MXPA02006489A (de)
PT (1) PT1242119E (de)
TR (1) TR200401363T4 (de)
WO (1) WO2001049242A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
WO2002024207A1 (en) * 2000-09-21 2002-03-28 Henderson Morley Research & Development Limited Diuretic or sulphonylurea for use in antiviral treatment
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats
US7534768B2 (en) * 2000-12-13 2009-05-19 Henderson Morely Research And Development Ltd. Treatment of DNA viral infections
US20060234955A1 (en) * 2002-05-28 2006-10-19 Bette Pollard Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
CN1758905A (zh) 2003-02-12 2006-04-12 乔治敦大学 青蒿素在治疗致癌病毒诱导的肿瘤和治疗病毒感染中的应用
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections
CN106562982A (zh) * 2016-09-27 2017-04-19 苏州系统医学研究所 强心苷类化合物在抗埃博拉病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240732A (ja) * 1990-02-14 1991-10-28 Yasuo Tanaka 抗ウイルス剤
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
AU5492899A (en) * 1998-08-24 2000-03-14 Hadasit Medical Research Services & Development Company Ltd The use of loop diuretics for hiv infection
KR20020073156A (ko) * 1999-12-30 2002-09-19 헨더슨 몰리 리서치 앤드 디벨럽먼트 리미티드 Ｄｎａ 바이러스 감염의 시너지 치료

Also Published As

Publication number Publication date
AU1873401A (en) 2001-07-16
MXPA02006489A (es) 2003-09-22
DE60009146T2 (de) 2005-02-17
CA2395016C (en) 2009-04-14
KR100843790B1 (ko) 2008-07-03
ATE261737T1 (de) 2004-04-15
IL150286A0 (en) 2002-12-01
KR20030005162A (ko) 2003-01-17
US6894030B2 (en) 2005-05-17
EP1242119B1 (de) 2004-03-17
CA2395016A1 (en) 2001-07-12
CN1414863A (zh) 2003-04-30
DK1242119T3 (da) 2004-08-02
WO2001049242A3 (en) 2002-07-11
US20030050253A1 (en) 2003-03-13
BR0016831A (pt) 2002-09-10
AU777339B2 (en) 2004-10-14
EP1242119A2 (de) 2002-09-25
TR200401363T4 (tr) 2004-08-23
PT1242119E (pt) 2004-08-31
WO2001049242A2 (en) 2001-07-12
JP2003519163A (ja) 2003-06-17
ES2218254T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
DE60009146D1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
ES2187798T3 (es) Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento.
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE29602789U1 (de) Liege, Decke o.dgl. zur therapeutischen Behandlung von Lebewesen
ES2173923T3 (es) Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente.
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ATE306275T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE60024969D1 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
DE60009069D1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
DE60002172D1 (de) Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol in hbv
ATE165508T1 (de) Verwendung von 2-methylamino-2-phenylcyclohexanon zur behandlung von infektionen und zur immunmodulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition